|

Depression Clinical Trials in Jacksonville, FL

18 recruiting studies within 50 miles

Phase
Trial Phase Dist.
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia SymptomsPhase 3<1 mi
Study to Assess the Safety and Effectiveness of NMRA-335140-501Phase 3<1 mi
Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive DisorderPhase 3<1 mi
A Phase 3 Trial of MM120 for Major Depressive Disorder (Emerge)Phase 3<1 mi
GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive DisorderPhase 2<1 mi
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)Phase 3<1 mi
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)Phase 2<1 mi
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive SymptomsPhase 4<1 mi
A Study of Ketamine Infusions to Treat Clinically-depressed ICU PatientsPhase 2<1 mi
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive DisorderPhase 2<1 mi
A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive DisorderPhase 2<1 mi
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive DisorderPhase 3<1 mi
A Randomized Study of Azetukalner Versus Placebo in Major Depressive DisorderPhase 3<1 mi
GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder With Comorbid Anxiety and InsomniaPhase 2<1 mi
Potential Benefits of Parent Child Interaction Therapy (PCIT)—<1 mi
Virtual Reality Intervention to Improve Psychological Symptom Burden for Cancer Patients Undergoing TreatmentN/A<1 mi
E-Mindfulness Approaches for Living After Breast CancerPhase 3<1 mi
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant DepressionN/A37 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.